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cholecystectomyAbstract Background: Laparoscopic surgical procedures have various benefits to the patient in
terms of decreased tissue damage, early ambulation, decreased hospital stay and reduced analgesic
needs. Pneumoperitoneumwith carbon dioxide (CO2) leads to stimulation of the sympathetic nervous
system which can be a risk factor in patients with cardiovascular diseases. Moreover, reverse Trende-
lenburg position affects homeostasis in laparoscopic surgeries. In this study, we compared the efficacy
of clonidine (which is a2 adrenergic agonist) versus esmolol (which is ultra short acting cardio-
selective b1-receptor antagonist) on the hemodynamic response during laparoscopic cholecystectomy.
Materials and methods: A total of 60 patients scheduled to undergo laparoscopic cholecystectomy
were randomly assigned into two groups: Group C: received 2 lg/kg of clonidine diluted in 20 ml nor-
mal saline, given with slow intravenous infusion over 10 min just before induction of GA and Group
E: received 1.5 mg/kg of esmolol as a loading dose over a period of 5 min just before induction of GA
followed by 10 lg/kg/min as a maintenance dose throughout the procedure. No hypnotic medication
was given on the evening before surgery. Systolic, diastolic, mean arterial blood pressures and heart
rate were recorded at (1) baseline, (2) three minutes after endotracheal intubation, (3) before
pneumoperitoneum, (4) fifteen minutes after pneumoperitoneum, (5) thirty minutes after
pneumoperitoneum, (6) fiveminutes after release of CO2 and (7) fiveminutes after extubation. Degree
of sedation according to Ramsay sedation score was assessed 15 min after reaching PACU.
Results: Both groups were similar with respect to demographic data. Clonidine group showed more
stability in hemodynamic responses than esmolol group in all hemodynamic variables but with more
postoperative sedation.
Conclusion: This study concluded that clonidine and esmolol provide hemodynamic stability in
laparoscopic cholecystectomy but clonidine provides more stability with postoperative sedation.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Laparoscopy has now become the standard technique of
choice for cholecystectomy. Laparoscopic surgical procedures
have various benefits to the patient in terms of decreased tis-
sue damage, early ambulation, decreased hospital stay and
reduced analgesic needs. The hallmark of laparoscopy is the
creation of pneumoperitoneum with carbon dioxide (CO2)
which leads to stimulation of the sympathetic nervous system
resulting in pathophysiological changes characterized by
increase in arterial pressure and systemic and pulmonary vas-
cular resistance (SVR and PVR) early after the beginning of
intra-abdominal insufflation with little change in heart rate
(HR) which can be a risk factor for adverse cardiologic
events in patients with pre-existing essential hypertension,
ischemic cardiac disease, or increased intra-cranial or intra-
ocular pressure [1–4]. Moreover, there is a significant change
in the homeostasis observed in reverse Trendelenburg
position used for laparoscopic surgeries. In addition, the
anesthetic agents put together alter the cardiopulmonary
function significantly [5].
Different pharmacological agents such as a2 adrenergic
agonists, magnesium sulfate [6], beta-blockers [7] and opioids
[8] are used to attenuate circulatory response due to pneu-
moperitoneum. Clonidine is a selective a2 adrenergic agonist
which causes fall in blood pressure and heart rate (HR) with
decreased SVR and cardiac output [9]. Esmolol, an ultra
short-acting cardio-selective b1-receptor antagonist, has been
shown to blunt hemodynamic responses to perioperative nox-
ious stimuli [10]. Hence, the present randomized study was
designed to evaluate and compare the efficacy of clonidine ver-
sus esmolol on hemodynamic response during laparoscopic
cholecystectomy. In other words, the rationale of the study
was to reach laparoscopic cholecystectomy with stable
hemodynamics.
2. Materials and methods
This was a randomized, double blind, comparative clinical
study performed in Ain shams University Hospitals from
November 2014 till May 2015. After getting approval from
the institutional ethical committee, an informed consent was
taken from every patient enrolled in the study.
Sixty patients aged P20–660 years, ASA physical status I
or II, planned for elective laparoscopic cholecystectomy were
included. The exclusion criteria included the following: ASA
physical status > 2, taking beta-blocking drugs or sedatives
or antihypertensives or antipsychotics or analgesics, inability
to communicate with the patient due to any reason, patients
with neurologic, cardiovascular, renal, hepatic diseases or dia-
betes mellitus, pregnant or breast-feeding females, duration of
procedure lasting for more than 120 min and anticipated diffi-
cult airway.
2.1. Method of randomization
Patients were allocated randomly by a computer generated list
of random permutations to one of two equal groups (30
patients each): group C and group E.– Group C: Received 2 lg/kg of clonidine diluted in 20 ml
normal saline, given with slow intravenous infusion over
10 min just before induction of GA.
– Group E: Received 1.5 mg/kg of esmolol as a loading dose
over a period of 5 min just before induction of GA followed
by 10 lg/kg/min as a maintenance dose throughout the
procedure.
Randomization sequence was concealed in sealed envelopes
performed by the help of an independent personnel. An
appropriate code number was assigned to each patient, with
an allocation ratio of 1:1. The study solutions were prepared
and injected by an attending anesthesiologist who was not
involved in the patient care or data collection. All patients,
investigators and anesthesiologists were blinded to the infusion
administered. Drug administration and data collection were
carried out by investigators in a double-blind manner.
No hypnotic medication was given on the evening before
surgery. Patients were premedicated with glycopyrrolate
0.02 mg/kg i.v. and ondansetron 4 mg i.v. in the preoperative
room. Upon arrival in the operating room, monitors
were attached to the patients and baseline parameters (heart
rate, NIBP, oxygen saturation, temperature and end tidal
CO2, and ECG) were recorded.
After pre-oxygenation with O2 100% for 3 min, anesthesia
was induced with a standard anesthetic protocol using
midazolam 0.03 mg/kg, fentanyl 1 lg/kg, thiopentone sodium
3–5 mg/kg, and tracheal intubation was facilitated by
atracurium 0.5 mg/kg intravenously. Lungs were mechanically
ventilated with O2 50% and anesthesia was maintained with
isoflurane 0.8% and atracurium 0.1 mg/kg every 25 min.
Ventilation was adjusted to maintain normocapnia (end-tidal
carbon dioxide [EtCO2] 40 ± 5 mmHg). Pneumoperitoneum
was created by insufflations of CO2 and operation table was
tilted to about 15 reverse Trendelenberg. Intra-abdominal
pressure was not allowed to exceed more than 14 mmHg. After
1 h of surgery, each patient received 1 g paracetamol infused
over 30 min intravenously. During surgery, Ringer’s lactate
solution was administered in maintenance dose as per
Holliday-Segar formula. Any hypotension (MAP< 20%
preoperative) was managed with a fluid bolus of normal saline
250–300 ml. If hypotension did not respond to fluid adminis-
tration, then ephedrine 15 mg i.v. was ready to be adminis-
tered. Any incidence of bradycardia (HR< 50/min) was
treated with atropine 0.7 mg i.v.
At the end of surgery, residual neuromuscular block was
reversed by the injection of neostigmine 0.05 mg/kg and
glycopyrrolate 0.02 mg/kg i.v. and patient was extubated when
respiration was sufficient, and they were able to obey com-
mands. Esmolol infusion was stopped 5 min after extubation.
Patients were transferred to the postanesthesia care unit
(PACU) where they were monitored for any evidence of com-
plications or adverse events. Systolic, diastolic, mean arterial
blood pressures and heart rate were recorded at the following
points of time:
(1) Prior to induction before receiving clonidine or esmolol
(baseline).
(2) Three minutes after endotracheal intubation.
(3) Before pneumoperitoneum.
(4) Fifteen minutes after pneumoperitoneum.
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(6) Five minutes after release of CO2.
(7) Five minutes after extubation.
Degree of sedation according to Ramsay sedation score was
assessed 15 min after reaching PACU. Level of sedation score
was as follows: 0 Awake and agitated 1 Awake and comfort-
able 2 Asleep and arousable 3 Asleep with sluggish response
to verbal commands or touch 4 No response to verbal com-
mand or touch. The results obtained in the study are presented
in tabulated manner.
The primary outcomes of our study were as follows: systolic
blood pressure, diastolic blood pressure, mean blood pressure
and heart rate. The secondary outcomes were as follows:
postoperative sedation and any possible side effects of the 2
drugs.
2.2. Statistics
Statistical presentation and analysis of the present study were
conducted, using the mean, standard deviation, Chi-square,
paired t-test and unpaired t-test by SPSS V17. Unpaired
Student T-test was used to compare between related samples.Table 1 Demographic data.
Group C
(n= 30)
Group E
(n= 30)
Tests
X2/t P-value
Sex
Female 22(73.3%) 24(80%) 0.373 0.542
Male 8(26.7%) 6(20%)
Age
Mean ± SD 43.63 ± 4.46 45.20 ± 4.96 1.287 0.203
Weight
Mean ± SD 71.53 ± 7.98 73.03 ± 8.09 0.723 0.472
ASA
I 19(63.3%) 17(56.7%) 0.278 0.598
II 11(36.7%) 13(43.3%)
Table 2 Changes in systolic arterial pressure.
SBP Groups
Group C (n= 30)
Mean ± SD
Baseline 119.77 ± 3.51
3 min after intubation 122.23 ± 2.19
Before pp 115.20 ± 2.66
15 after pp 118.10 ± 2.44
30 after pp 118.63 ± 2.57
5 min after CO2 114.33 ± 2.45
5 min after extubation 109.90 ± 2.55
Paired t-test
3 min after intubation 0.005*
Before PP 0.004*
15 after PP 0.017*
30 after PP 0.019*
5 min after CO2 <0.001
*
5 min after ext. <0.001*Fisher’s exact test and Yates’ corrected chi-square are com-
puted for 2  2 tables.
2.3. Sample size
The sample size was calculated using Epicalc 2000 software
depending on the results from previous studies [6,7] with the
following parameters:
Type I error (a) = 5% with confidence level 95% and
power of study 90% (power of test) with type error II 10%
(Beta) with expected difference of 0.36. The minimal sample
size was 28 in each group. A total of 30 patients in each group
were included to compensate for possible dropouts. Corre-
sponding P was computed. P< 0.05 was considered as statis-
tically significant.
3. Results
There were no significant differences between the two groups
with regard to demographic data such as age, sex, weight
and ASA grade (Table 1).
Preoperative vital data before induction (SBP, DBP, MBP
and HR) were compared between the two groups of patients
and no significant difference was found (baseline values of
Tables 2–5). Systolic arterial pressure, diastolic blood pressure
and mean blood pressure increased slightly after intubation in
both groups and then decreased significantly intraoperatively
and after extubation compared to baseline values but it was
significantly lower in group C compared with group E (Tables
2–4) and (Figs. 1–3). One patient suffered from significant
hypotension in group C which was managed with a fluid bolus
of normal saline 300 ml and ephedrine 15 mg i.v.
After intubation and till 5 min after extubation, mean HR
values measured were significantly lower in group C compared
to group E and in both groups the values were lower than
baseline values except in group E 3 min after intubation (mean
value was slightly higher than baseline value) (Table 5 and
Fig. 4).
2 patients in group C required intravenous atropine due to
bradycardia (HR< 50).Group E (n= 30) T-test
Mean ± SD t P-value
118.40 ± 2.62 1.713 0.092
127.90 ± 1.63 11.371 <0.001*
121.57 ± 1.98 10.528 <0.001*
124.80 ± 1.69 12.363 <0.001*
124.77 ± 1.68 10.962 <0.001*
120.17 ± 2.05 9.987 <0.001*
119.47 ± 2.27 15.345 <0.001*
<0.001*
<0.001*
<0.001*
<0.001*
0.006*
0.019*
Table 3 Changes in diastolic arterial pressure.
DBP Groups
Group C (n= 30) Group E (n= 30) T-test
Mean ± SD Mean ± SD t P-value
Baseline 79.37 ± 1.82 78.70 ± 1.51 1.552 0.126
3 MIN AFTER INT. 81.90 ± 0.92 84.03 ± 1.00 8.589 <0.001*
Before PP 75.17 ± 1.05 81.17 ± 0.91 23.579 <0.001*
15 min after PP 75.63 ± 1.88 84.13 ± 0.90 22.297 <0.001*
30 min after PP 74.73 ± 1.74 83.13 ± 0.94 23.273 <0.001*
5 min after CO2 71.87 ± 1.74 81.13 ± 0.94 25.720 <0.001
*
5 min after extubation 73.80 ± 1.61 79.13 ± 0.94 15.710 <0.001*
Paired t-test
3 min after intubation 0.011* <0.001*
Before PP <0.001* <0.001*
15 min. after PP <0.001* <0.001*
30 min. PP <0.001* <0.001*
5 min. after CO2 <0.001
* <0.001*
5 min. after extubation <0.001* 0.010*
Table 4 Changes in mean arterial pressure.
MBP Groups
Group C (n= 30) Group E (n= 30) T-test
Mean ± SD Mean ± SD t P-value
Baseline 92.30 ± 2.96 91.20 ± 2.78 1.484 0.143
3 min after intubation 93.13 ± 2.80 98.60 ± 1.35 11.385 <0.001*
Before PP 84.40 ± 2.75 94.07 ± 1.14 17.783 <0.001*
15 min. after PP 86.57 ± 2.81 93.30 ± 1.44 8.203 <0.001*
30 min. after PP 86.24 ± 2.82 93.04 ± 1.52 8.206 <0.001*
5 min. after CO2 83.27 ± 2.73 87.72 ± 1.60 7.712 <0.001
*
5 min. after extubation 82.73 ± 2.58 86.83 ± 1.53 7.478 <0.001*
Paired t-test
3 min. after intubation 0.015* <0.001*
Before PP <0.001* <0.001*
15 min. after PP <0.001* 0.007*
30 min. after PP <0.001* <0.001*
5 min. after CO2 <0.001
* <0.001*
5 min. after extubation <0.001* <0.001*
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assessed in patients 15 min after reaching PACU. The mean
score in group C was significantly higher than the mean score
in group E (Table 6).4. Discussion
Our study confirms that clonidine and esmolol can successfully
control hemodynamic changes in laparoscopic cholecystec-
tomy; however clonidine has stronger effects on the hemody-
namics with a sedative effect.
Laparoscopic cholecystectomy is considered a minimally
invasive procedure. Hemodynamic changes with pneumoperi-
toneum were first recognized in 1947 [11]. Pneumoperitoneum
using CO2 for laparoscopic surgery causes a rapid and imme-
diate increase in plasma catecholamines and vasopressin
[12,13] possibly due to an increase in intraperitoneal pressureand stimulation of the peritoneum by CO2. At intra-
abdominal pressure of 15 mmHg, Joris et al. [4] found a
35% increase in mean arterial pressure, a 65% increase in sys-
temic vascular resistance, and a 90% increase in pulmonary
vascular resistance, while there was a 20% decrease in cardiac
output. Plasma concentrations of renin also increase during
laparoscopy [14]. The increase in catecholamines, renin and
vasopressin induces a cardiovascular response characterized
by abrupt elevations of arterial pressure, SVR and HR [15].
The increase in these hemodynamic values significantly
increases the incidence of myocardial ischemia, infarction
and other complications [16]. Various techniques such as gas-
less approach and many pharmacological agents have been
used to counteract these detrimental effects of pneumoperi-
toneum. On the other hand, laryngoscopic stimulation of
oropharyngeal structures may be an important factor in hemo-
dynamic stress response associated with tracheal intubation
[17]. Instrumentation of the pharynx and tracheal intubation
Table 5 Changes in heart rate.
HR Groups
Group C (n= 30) Group E (n= 30) T-test
Mean ± SD Mean ± SD t P-value
Baseline 85.03 ± 2.27 84.20 ± 1.81 1.566 0.123
3 min. after intubation 84.03 ± 1.27 89.23 ± 1.25 15.962 <0.001*
Before PP 76.27 ± 2.29 81.93 ± 1.28 11.827 <0.001*
15 min. after PP 74.27 ± 2.16 78.93 ± 1.31 10.100 <0.001*
30 min. after pp 73.20 ± 2.11 79.33 ± 1.81 12.102 <0.001*
5 min. after CO2 72.87 ± 2.08 81.40 ± 1.98 16.292 <0.001
*
5 min. after extubation 69.93 ± 2.20 79.60 ± 1.81 18.597 <0.001*
Paired t-test
3 min. after intubation 0.023* <0.001*
Before PP <0.001* <0.001*
15 min. after pp <0.001* <0.001*
30 min. after pp <0.001* <0.001*
5 min. after CO2 <0.001
* <0.001*
5 min. after extubation <0.001* <0.001*
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Table 6 Sedation score comparison between the two groups.
Groups Score ANOVA
Range Mean ± SD f P-value
Group C (n= 30) 1–4 2.53 ± 0.86 7.196 <0.001*
Group E (n= 30) 0–2 1.13 ± 0.63
PP: pneumoperitoneum.
* Statistically significant.
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cholamine concentration that may evoke life threatening con-
dition among susceptible individuals especially those with
cardiovascular disease [18]. Also it may lead to occasional
arrythmias, cough reflexes, increased intracranial pressure,
and increased intraocular pressure. If no specific measures
are taken to prevent the hemodynamic response, the HR can
increase from 26% to 66% depending on the method of induc-
tion, and SBP can increase from 36% to 45% [19].
Our study compared between clonidine and esmolol
because both of these drugs antagonize such hemodynamic
changes during laparoscopy surgeries. Clonidine, a selective
a-2 adrenergic agonist, has desirable actions such as anxiolysis,sedation, analgesia, antiemesis, and prevention of shivering. It
is a potent hypotensive agent. Clonidine inhibits cate-
cholamine and vasopressin-mediated increase in SVR caused
by pneumoperitoneum [20]. Numerous studies using intra-
venous clonidine found effective prevention of hemodynamic
derangements because of intubation and during laparoscopic
cholecystectomy [21,22]. However, higher doses of clonidine
resulted in significant bradycardia and hypotension [23].
Malek et al. [24] used 150 lg of clonidine as intravenous infu-
sion while Sung et al. [25] and Yu et al. [26] used 150 lg of oral
clonidine as premedication for maintenance of hemodynamic
stability during pneumoperitoneum. Yu et al. even recom-
mended its routine use as premedication in laparoscopic surg-
eries. Das et al. [27] also used 150 lg of oral clonidine 90 min
prior to surgery to prevent hemodynamic response to pneu-
moperitoneum in laparoscopic cholecystectomy. Kalra et al.
[28] used clonidine 1 lg/kg intravenously over a period of
15 min before pneumoperitoneum and clonidine group
patients showed significantly better hemodynamic control than
control group.
b-adrenergic receptor antagonists have also been used by
various authors during surgery with the intention to attenuate
the stress response of intubation and decrease the unwanted
perioperative hemodynamic changes [29]. Esmolol is the selec-
tive b-adrenergic receptor blocker available and with its rapid
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to be an ideal drug for preventing acute increases in HR and
SAP [30].
As an optimal intravenous (IV) esmolol dose for use during
anesthesia induction (laryngoscopy and intubation) and emer-
gence (extubation) has been previously determined in some
studies to be 1.5 mg/kg, we used the same bolus dose in our
study [31,32]. Moreover, many studies have demonstrated that
beta adrenergic blockers that exert depressive effects on the
central nervous system as esmolol also decreases the need for
intraoperative anesthetic agents, leading to rapid recovery
from anesthesia [31,33,34].
In this study, we compared between clonidine and esmolol
in reduction of stress response and hemodynamic changes
associated with laparoscopy. Both groups showed attenuation
in SBP, DBP, MBP and HR increases in response to intuba-
tion with group C showing little increases compared to group
E which was statistically significant. It was found that the SBP,
DBP, and MBP values were lower with clonidine group com-
pared to baseline values during pneumoperitoneum, release of
CO2 and after extubation than esmolol group and it was statis-
tically significant. Just one patient in clonidine group suffered
from significant hypotension but it was managed rapidly with
fluids and ephedrine. Generally, the fluctuations in blood pres-
sure during such operation were attenuated in both groups;
therefore, we can safely conclude that clonidine and esmolol
stabilize blood pressure during various phases of anesthesia
and laparoscopy. After intubation, esmolol group showed little
increase in mean heart rate compared to baseline value while in
clonidine group, mean heart rate was lower than baseline
value. However, the heart rate was lower in both groups
during the surgery as compared to baseline values and it
was statistically significant. Moreover, the mean heart rate
was lower in group C compared with group E throughout
the procedure and it was statistically significant. In spite of
its more pronounced effect on heart rate, just 2 patients receiv-
ing clonidine suffered from significant bradycardia and
required atropine injection. None of esmolol group suffered
from bradycardia. Definitely, the heart rate lowering effect
of both study drugs reduces the myocardial oxygen demand
of the patient which can be very useful in patients suffering
from coronary artery disease. The sedative effect of clonidine
was obvious postoperatively compared with esmolol group
but sedation was not that deep as patients were arousable
either verbally or by touch.
5. Conclusion
In laparoscopic cholecystectomy the use of clonidine or
esmolol will provide hemodynamic stability but with a
postoperative sedative effect more with clonidine.
Source of funding
No funding.
Conflict of interests
No conflict of interests.References
[1] Joris J. Anesthetic management of laparoscopy. In: Miller’s
Anesthesia. New York: Churchill Livingstone; 1994. p. 2011–29.
[2] Wabha RW, Beique F, Kleiman SJ. Cardiopulmonary function
and laparoscopic cholecystectomy. Can J Anaesth
1995;42:51–63.
[3] Sharma KC, Brandstetter RD, Brensilver JM, Jung LD.
Cardiopulmonary physiology and pathophysiology as a
consequence of laparoscopic surgery. Chest 1996;110:810–5.
[4] Joris JL, Noirot DP, Legrand MJ, Jacquet NJ, Lamy ML.
Hemodynamic changes during laparoscopic cholecystectomy.
Anesth Analg 1993;75:1067–71.
[5] Jean LJ. Anaesthesia for laparoscopic surgery. In: Miller RD,
editor. Anesthesia. New York: Churchill Livingstone; 2010. p.
2185–202.
[6] Kalra NK, Verma A, Agarwal A, Pandey HD. Comparative
study of intravenously administered clonidine and magnesium
sulfate on hemodynamic responses during laparoscopic
cholecystectomy. J Anaesthesiol Clin Pharmacol 2011;27:344–8.
[7] Koivusalo AM, Scheinin M, Tikkanen I, et al. Effects of esmolol
on haemodynamic response to CO2 pneumoperitoneum for
laparoscopic surgery. Acta Anaesthesiol Scand 1998;42:510–7.
[8] Lentschener C, Axler O, Fernandez H, et al. Haemodynamic
changes and vasopressin release are not consistently associated
with carbon dioxide pneumoperitoneum in humans. Acta
Anaesthesiol Scand 2001;45:527–35.
[9] Sung CS, Lin SH, Chan KH, Chang WK, Chow LH, Lee TY.
Effect of oral clonidine premedication on perioperative
haemodynamic response and postoperative analgesic
requirement for patients undergoing laparoscopic
cholecystectomy. Acta Anaesthesiol Sin 2000;38:23–9.
[10] White PF, Wang B, Tang J, Wender RH, Naruse R, Sloninsky
A. The effect of intraoperative use of esmolol and nicardipine on
recovery after ambulatory surgery. Anesth Analg 2003;97
(6):1633–8.
[11] Booker WM, French DM, Molano PA. Further studies on the
acute effects of intra abdominal pressure. Am J Physiol
1947;149:292–8.
[12] Myre K, Rostrup M, Buanes T, Stokland O. Plasma
catecholamines and haemodynamic changes during
pneumoperitoneum. Acta Anaesthesiol Scand 1998;42(3):343–7.
[13] Mann C, Boccara G, Pouzeratte Y, Eliet J, Serradel-Le Gal C,
Vergnes C, et al. The relationship among carbon dioxide
pneumoperitoneum, vasopressin release, and hemodynamic
changes. Anesth Analg 1999;89(2):278–83.
[14] Baratz RA, Karis JH. Blood gas studies during laparoscopy
under general anesthesia. Anesthesiology 1969;30:463–4.
[15] Larsen JF, Svendsen FM, Pedersen V. Randomized clinical trial
of the effect of pneumoperitoneum on cardiac function and
haemodynamics during laparoscopic cholecystectomy. Br J Surg
2004;91(7):848–54.
[16] McLaughlin JG, Scheeres DE, Dean RJ, Bonnell BW. The
adverse hemodynamic effects of laparoscopic cholecystectomy.
Surg Endosc 1995;9(2):121–4.
[17] Kihara S, Brimacombe J, Yuguchi Y, Watanabe S, Taguchi N,
Kumatsuzaki T. Haemodynamic responses among three
tracheal intubation devices in normotensive and hypertensive
patients. Anaesth Analg 2003;96:890–5.
[18] Kim, Woon-Young, Lee, Yoon-Sook, Ok, Se Jim, Kim, Jac-
Hwan, Park, Young-Cheol, Lim, Hye-Ja. Lidocaine does not
prevent bispectral index increases in response to endotracheal
intubation. Anaesth Analg 2006; 102: 156–9 [International
Anaesthesia Research Society].
[19] Wylie, Churchill Davidson. Stress management. A practice of
anesthesia. London: Arnold; 2003, ISBN 0340731303. p. 1326.
44 A.N. Ibrahim et al.[20] Zalunardo MP, Zollinger A, Spahn DR, Seifert B, Radjaipour
M, Gautschi K, et al. Effects of intravenous and oral clonidine
on hemodynamic and plasma-catecholamine response due to
endotracheal intubation. J Clin Anesth 1997;9(2):143–7.
[21] Laisalmi M, Koivusalo AM, Valta P, Tikkanen I, Lindgren L.
Clonidine provides opioid-sparing effect, stable hemodynamics,
and renal integrity during laparoscopic cholecystectomy. Surg
Endosc 2001;15(11):1331–5.
[22] Ma´lek J, Knor J, Kurzova´ A, Lopourova´ M. Adverse
hemodynamic changes during laparoscopic cholecystectomy
and their possible suppression with clonidine premedication.
Comparison with intravenous and intramuscular premedication.
Rozhl Chir 1999;78:286–91.
[23] Ray M, Bhattacharjee DP, Hajra B, Pal R, Chatterjee N. Effect
of clonidine and magnesium sulphate on anaesthetic
consumption, haemodynamics and postoperative recovery: a
comparative study. Indian J Anaesth 2010;54:137–41.
[24] Malek J, Knor J, Kurzova A, Lopourova M. Adverse
hemodynamic changes during laparoscopic cholecystectomy
and their possible suppression with clonidine premedication.
Comparison with intravenous and intramuscular premedication.
Rozhl Chir 1999;78:286–91.
[25] Sung CS, Lin SH, Chan KH, Chang WK, Chow LH, Lee TY.
Effect of oral clonidine premedication on perioperative
hemodynamic response and postoperative analgesic
requirement for patients undergoing laparoscopic
cholecystectomy. Acta Anaesthesiol Sin 2000;38:23–9.
[26] Yu HP, Hseu SS, Yien HW, Teng YH, Chan KH. Oral clonidine
premedication preserves heart rate variability for patients
undergoing laparoscopic cholecystectomy. Acta Anaesthesiol
Scand 2003;47:185–90.[27] Mrinmoy Das, Manjushree Ray, Gauri Mukherjee.
Hemodynamic changes during laparoscopic cholecystectomy:
effect of oral clonidine premedication. Indian J Anaesth
2007;51:205–10.
[28] Kalra NK, Verma A, Agarwal A, Pandey HD. Comparative
study of intravenously administered clonidine and magnesium
sulfate on hemodynamic responses during laparoscopic
cholecystectomy. J Anaesthesiol Clin Pharmacol 2011;27:344–8.
[29] Koivusalo AM, Scheinin M, Tikkanen I, Yli-Suomu T, Ristkari
S, Laakso J, Lindgren L. Effects of esmolol on haemodynamic
response to CO2 pneumoperitoneum for laparoscopic surgery.
Acta Anaesthesiol Scand 1998;42(5):510–7.
[30] Gorczynski RJ, Shaffer JE, Lee RJ. Pharmacology of ASL-
8052, a novel beta-adrenergic receptor antagonist with an
ultrashort duration of action. J Cardiovasc Pharmacol 1983;5
(6):77.
[31] White PF, Wang B, Tang J, et al. The effect of intraoperative use
of esmolol and nicardipine on recovery after ambulatory
surgery. Anesth Analg 2003;97:1633–8.
[32] Topcu I, Ozturk T, Tasyuz T, et al. The effects of esmolol on
anesthetic and analgesic requirement. Turk J Anaesth Reanim
2007;35:393–8.
[33] Collard V, Mistraletti G, Taqi A, et al. Intraoperative esmolol
infusion in the absence of opioids spares postoperative fentanyl
in patients undergoing ambulatory laparoscopic
cholecystectomy. Anesth Analg 2007;105:1255–62.
[34] Smith I, Hemelrijck JV, White PF. Efficacy of esmolol versus
alfentanil as a supplement to propofol-nitrous oxide anesthesia.
Anesth Analg 1991;73:540–6.
